Targeted Therapies & Drug Design: Dr. Hemant R. Jadhav’s Insights Kumar Jeetendra | June 14, 2025 Dr. Hemant R. Jadhav, a BITS Pilani professor, spends his days sketching tiny drug-like shapes on a computer screen and nights watching them grow into real compounds. His work targets cancer, HIV, Alzheimer’s, and diabetes—blending molecular design with hands-on testing to yield future-ready therapies. At the core of his research are histone demethylases—epigenetic gatekeepers that …